Edaravone for patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis.

Due to the limited number of studies and confounding issues in observational studies, further examination of the added benefits of edaravone to routine practice is necessary through RCTs, particularly regarding its long-term efficacy.